Cognition Therapeutics Gains FDA Alignment for Phase 3 Trial
Cognition Therapeutics announces FDA alignment on its Phase 3 trial for zervimesine, a treatment for dementia with Lewy bodies.
Worthington Steel's Kloeckner Agreement Fails Shareholder Vote
Worthington Steel's proposed agreement with Kloeckner fails to gain shareholder approval, impacting future strategies and operational plans.
Federal Home Loan Bank of Boston Reports Q3 Results, Declares Dividend
Federal Home Loan Bank of Boston reports Q3 net income of $66.4 million and declares a 6.72% dividend, emphasizing its strong financial health.
Innventure, Inc. Faces Delisting from Nasdaq Due to Bid Price
Innventure, Inc. is at risk of delisting from Nasdaq after failing to meet the minimum bid price requirement, highlighting challenges in the blank check sector.
Healthcare Triangle approves reverse stock split measures
Healthcare Triangle, Inc. stockholders approve reverse stock splits to stabilize share price and comply with Nasdaq regulations.
Tompkins Financial reports Q3 results, announces dividend increase
Tompkins Financial Corp reports a 21% rise in Q3 net income and announces a dividend increase, signaling strong performance in the banking sector.
RMX Industries Secures $295,550 Financing from Vanquish Group
RMX Industries, Inc. has secured a $295,550 financing deal with Vanquish Funding Group to enhance working capital, with potential for $1.1 million more.
Canopy Growth shareholders approve key proposals at AGM
Canopy Growth Corp. held its Annual General Meeting, where shareholders approved the election of directors and an auditor, among other proposals.
Tempus AI, Inc. Secures $192.5 Million in Data Agreements
Tempus AI, Inc. announces $192.5 million agreements with Bristol-Myers Squibb and Pathos AI to enhance oncology and neurology data access.
Arcosa Completes Merger with CRH Americas, Changes Control
Arcosa, Inc. has finalized its merger with CRH Americas, transforming its operational structure and impacting the fabricated structural metal products industry.
Steele Bancorp reports Q3 2026 earnings drop post-merger
Steele Bancorp, Inc. announces a significant decline in Q3 2026 earnings, reflecting the impact of its merger with Northumberland Bancorp.
UWM Holdings reports Q3 2026 results, announces rights offering
UWM Holdings Corp reveals preliminary Q3 2026 financial results and launches a rights offering to raise up to $400 million.
LKQ Corporation appoints Salvatore Abbate as new CEO
LKQ Corporation announces Salvatore A. Abbate as new CEO, succeeding Justin L. Jude, effective December 15, 2026, enhancing leadership in the vehicle parts sector.
Winnebago Industries Enters Cooperation Agreement with Vision One
Winnebago Industries announces a cooperation agreement with Vision One Fund, including new director nomination and governance changes.
TeraWulf increases credit facility to $400 million in amendment
TeraWulf Inc. amends credit agreement, boosting revolving credit facility to $400 million, enhancing its financial strength in the finance services sector.
Transocean announces merger with Valaris, pending approvals
Transocean Ltd. reveals a merger with Valaris Limited, a strategic move in the drilling oil and gas wells sector, pending shareholder approvals.
Eastern Bankshares Reports Strong Q3 Earnings and Dividend
Eastern Bankshares, Inc. announces strong Q3 2026 earnings, highlighting growth and a quarterly dividend of $0.15 per share.
Gentex reports third-quarter results amid industry challenges
Gentex Corporation announces third-quarter financial results, showing resilience despite challenges in the automotive sector. Revenue declines noted.
Oric Pharmaceuticals updates on enozertinib program at ESMO
Oric Pharmaceuticals presents promising enozertinib data and plans Phase 3 trial for 2027, impacting the oncology pharmaceutical sector.
World Acceptance reports strong Q2 results, boosts buyback
World Acceptance Corporation posts strong Q2 results with increased net income and revenues, alongside a share repurchase announcement.